Hormonal changes after two bariatric surgeries in super-obese people
Official title: Comparison of Hormonal Response to a Mixed-Meal Tolerance Test After Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy With Duodenojejunal Bypass in Patients With Super Morbid Obesity: A Prospective Single-Center Non-Inferiority Randomized Clinical Trial
Run by Chulalongkorn University · NCT07747779 · Data updated 2026-11-12
This study tests whether sleeve gastrectomy with duodenojejunal bypass leads to different hormone responses and less post-meal hypoglycemia than Roux-en-Y gastric bypass in people with extreme obesity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | Chulalongkorn University Academic / other |
| Locations | 1 site (Pathum Wan, Bangkok) |
| Status | Recruiting |
| Started | August 8, 2024 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT07747779 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with BMI 50–60 kg/m2 seeking bariatric surgery, motivated to lose weight, and without diabetes or other major contraindications.
✕Probably not a fit
Patients with diabetes, significant comorbidities, prior bariatric surgery, or active reflux that disqualifies surgery may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial compares two surgical approaches for super morbid obesity to see how they affect gut hormone responses after a mixed meal. It will measure hormones such as GLP-1, GIP, glucagon, and insulin to understand underlying mechanisms of weight loss and glycemic changes. Participants are adults with BMI between 50 and 60 kg/m2 who qualify for bariatric surgery and do not have diabetes or other prohibitive conditions. The study is conducted at King Chulalongkorn Memorial Hospital in Bangkok under lead sponsor Chulalongkorn University. It is an interventional, procedure-based comparison without a specified randomized phase.
Why it matters
Potential benefit: If LSG-DJB shows a favorable hormonal profile and lower post-meal hypoglycemia, patients may experience better metabolic outcomes and fewer glucose-related problems after surgery.
How similar studies have gone: Previous data suggest LSG-DJB can achieve weight loss and glycemic control similar to LRYGB, but hormonal impacts are not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with an indication for bariatric surgery * BMI 50-60 kg/m2 * Patients who are motivated to lose weight but have not achieved successful weight reduction despite optimal medical therapy and exercise under physician supervision Exclusion Criteria: * Patients with diabetes mellitus * Patients with severe comorbid conditions that contraindicate surgery, such as advanced heart disease or chronic kidney failure * Patients with a history of previous bariatric surgery * Patients with gastroesophageal reflux disease refractory to medical therapy, large hiatal hernia, or endoscopic findings of reflux esophagitis grade C or D, or Barrett esophagus * Patients with psychiatric disorders that impair eating behavior control * Patients with a history of pancreatitis, pancreatic disease, or inflammatory bowel disease * Patients who have used steroids or GLP-1 receptor agonists within the past 2 months
Where it's running
-
King Chulalongkorn Memorial Hospital
Pathum Wan, Bangkok, Thailand Recruiting
Study contacts
- Principal investigator: Patchaya Boonchaya-anant, M.D. — King Chulalongkorn Memorial Hospital
- Study coordinator: Primploy Greeviroj, M.D., M.Sc.
- Email: primploy.gre@chulahospital.org
- Phone: +66917142555
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
15-year outcomes after sleeve gastrectomy in France
This study looks at how people who had sleeve gastrectomy have fared over 15 years to see long-term weight changes and health effects.
-
Mother and baby health after bariatric surgery in pregnancy
This study follows pregnant women who have had bariatric surgery and those who have not to see how nutrition, pregnancy health, and baby outcomes compare.
-
Understanding glucagon and sugar metabolism after meals in people with and without PBH after weight-loss surgery
This study tests how glucagon and post-meal glucose handling differ between people who have post-bariatric surgery hypoglycemia and those who don’t.
-
Collagen Supplements After Sleeve Gastrectomy
This observational study looks to see if taking collagen-containing supplements after sleeve gastrectomy affects muscle mass, body composition, and body image in adults who had bariatric surgery.
-
Postoperative nausea, vomiting and pain after bariatric surgery in Sweden
This study looks at how often people have nausea, vomiting, and pain after bariatric surgery in Sweden and whether anesthesia type or regional blocks affect those outcomes.
-
Sarcopenia After Bariatric Surgery: Changes in Muscle and Function
This study tests how bariatric surgery affects muscle mass, strength, and physical performance over time in adults undergoing the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.